Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
What ipsilateral lung constraints if any do you utilize for SBRT and or hypofractionated RT in the lungs?
Do you consider mean ipsilateral lung dose?
Related Questions
Is vocal cord paralysis a complication of thoracic RT?
Would a metal endobronchial stent within the treatment field change your radiation treatment plan for a thoracic malignancy?
How would you manage out-of-field nodal recurrence of NSCLC post definitive CRT and adjuvant immunotherapy?
What is the role of consolidative durvalumab and prophylactic cranial irradiation in patients with stage I small cell lung cancer?
When contouring locally advanced NSCLC, how do you define your ITV if your iGTV overlaps with an OAR?
For NSCLC patients treated with neoadjuvant chemoimmunotherapy and surgery with ypN2 disease, what factors would cause you to recommend PORT?
Is there a chest wall constraint you typically use for 60 Gy in 15 fraction NSCLC treatment?
Do you offer adjuvant durvalumab for stage I small cell lung cancer following SBRT or surgery?
How often, if ever, do patients with initially negative targetable mutation workup become positive later in recurrent lung cancer?
What constraints do you use for the BID small cell lung cancer regimen?